Pulmozyme and hepatic function abnormal Patient Reports February 12, 2012

Pulmozyme Side Effects Report #5958786-0
Pulmozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2007. Female patient was diagnosed with cystic fibrosis and was treated with Pulmozyme. After drug was administered, patient experienced the following side effects: haemoptysis, hepatic function abnormal, respiratory failure. Pulmozyme dosage: 2.5 MG, BID. During the same period patient was treated with COLISTIMETHATE, AZITHROMYCIN, CEFTAZIDIME, COLISTIN SULPHATE, ANTIBIOTIC NOS, TEICOPLANIN, CREON, VITAMIN A. Patient died on 06/08/2007.

Pulmozyme Side Effects Report #5960759-9
Pulmozyme side effect was reported by a Health Professional from NETHERLANDS on May 02, 2007. Female patient was diagnosed with cystic fibrosis and was treated with Pulmozyme. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Pulmozyme dosage: 1 MG/ML, UNK. Patient was hospitalized. Patient recovered.